毕得医药：前三季度实现营业收入9.79亿元

Core Insights - Bid Pharma reported a revenue of 979 million yuan and a net profit attributable to shareholders of 120 million yuan for the first three quarters, representing year-on-year growth of 20.7% and 42.8% respectively [1] - The basic earnings per share reached 1.37 yuan, an increase of 45.7% compared to the previous year [1] - The company attributed its revenue growth primarily to an increase in market demand [1]